CD90+ cells were isolated from these tumor specimens and were shown to exhibit an enhanced capacity to initiate tumor formation into immunodeficient mice, self-renew, differentiate and are resistant to standard cytotoxic drugs [108]; furthermore, CD90+ cells were shown to possess a high metastatic potential in vivo [108]. This evidence concerns the gene THY1 and neoplasm.